Abstract:Graphical and Lay Summary NADPH‐dependent oxidoreductases are important catalysts for production of chiral compounds, but insufficient supply of expensive nicotinamide cofactors have prevented their widespread exploitation. In this study, the authors developed a metabolic engineering strategy and a multienzyme modulation strategy for a NADPH‐dependent glufosinate dehydrogenases (GluDH) whole‐cell biocatalytic system to enhance intracellular NADP+ pool and catalytic efficiency. The cofactor self‐sufficient whole‐cell biocatalystic system was successfully applied for the asymmetric synthesis of L‐phosphinothricin, afformed a super high space‐time yield without the need to add exogenous cofactors. The engineering strategy might serve as a useful approach for constructing a cofactor self‐sufficient system of other oxidoreductases. NAD(P)H‐dependent oxidoreductases are crucial biocatalysts for synthesizing chiral compounds. Yet, the industrial implementation of enzymatic redox reactions is often hampered by an insufficient supply of expensive nicotinamide cofactors. Here, a cofactor self‐sufficient whole‐cell biocatalyst was developed for the enzymatic asymmetric reduction of 2‐oxo‐4‐[(hydroxy)(‐methyl)phosphinyl] butyric acid (PPO) to L‐phosphinothricin (L‐PPT). The endogenous NADP+ pool was significantly enhanced by regulating Preiss‐Handler pathway toward NAD(H) synthesis and, in the meantime, introducing NAD kinase to phosphorylate NAD(H) toward NADP+. The intracellular NADP(H) concentration displayed a 2.97‐fold increase with the strategy compared with the wild‐type strain. Furthermore, a recombinant multi‐enzyme cascade biocatalytic system was constructed based on the Escherichia coli chassis. In order to balance multi‐enzyme co‐expression levels, the strategy of modulating rate‐limiting enzyme PmGluDH by RBS strengths regulation successfully increased the catalytic efficiency of PPO conversion. Finally, the cofactor self‐sufficient whole‐cell biocatalyst effectively converted 300 mM PPO to L‐PPT in 2 h without the need to add exogenous cofactors, resulting in a 2.3‐fold increase in PPO conversion (%) from 43% to 100%, with a high space‐time yield of 706.2 g L−1 d−1 and 99.9% ee. Overall, this work demonstrates a technological example for constructing a cofactor self‐sufficient system for NADPH‐dependent redox biocatalysis.

New Strategy for Effective Biosynthesis of Chiral Aryl Alcohols: Co-Cultivation Microbe with Natural Deep-Eutectic Solvent

Design and evaluation of novel bio‐based deep eutectic solvents for highly efficient bioproduction of chiral aryl alcohol

Development of biocompatible DES/NADES as co-solvents for efficient biosynthesis of chiral alcohols

Synergistic promotion for microbial asymmetric preparation of (R)-2-chloro-1-(2,4-dichlorophenyl)ethanol by NADES and cyclodextrin

Effective Asymmetric Preparation of (R)-1-[3-(trifluoromethyl)phenyl]ethanol with Recombinant E. Coli Whole Cells in an Aqueous Tween-20/natural Deep Eutectic Solvent Solution.

A tandem and fully enzymatic procedure for the green resolution of chiral alcohols: acylation and deacylation in non-aqueous media

Efficient biosynthesis of (S)-1-[2-(trifluoromethyl)phenyl]ethanol by a novel isolate Geotrichum silvicola ZJPH1811 in deep eutectic solvent/cyclodextrin-containing system

Semi-rational Engineering of Carbonyl Reductase YueD for Efficient Biosynthesis of Halogenated Alcohols with in Situ Cofactor Regeneration

Efficient Synthesis of Chiral Aryl Alcohol with a Novel Kosakonia radicincitans Isolate in Tween 20/L-carnitine: Lysine-Containing Synergistic Reaction System

Biocatalytic Asymmetric Synthesis of Chiral Aryl Alcohols

Engineering carbonyl reductase for one-pot chemobiocatalytic enantioselective synthesis of value-added N-containing chiral alcohol from N-acetyl-D-glucosamine

Biocatalytic anti-Prelog reduction of prochiral ketones with whole cells of a newly isolated strain Empedobacter brevis ZJUY-1401

Asymmetric Bioreduction of 4-hydroxy-2-butanone by Carbonyl Reductases PFODH and CpSADH Delivers 1,3-butanediol Enantiomers with Excellent R - and S -enantioselectivity

Synthesis of enantiopure (S)-6-chlorochroman-4-ol using whole-cell Lactobacillus paracasei biotransformation

Asymmetric Reduction of Chloroacetophenones to Produce Chiral Alcohols with Microorganisms

Ethanol-assisted mechanochemical asymmetric cross-dehydrogenative coupling reaction with recoverable chiral amine/NaCl for accessing chiral α-alkyl α-glycine derivatives

Enhancing intracellular NADPH bioavailability through improving pentose phosphate pathway flux and its application in biocatalysis asymmetric reduction reaction

Biosynthesis of Chiral Amino Alcohols via an Engineered Amine Dehydrogenase in E. coli

Design of a cofactor self‐sufficient whole‐cell biocatalyst for enzymatic asymmetric reduction via engineered metabolic pathways and multi‐enzyme cascade

Efficient and Recyclable Photobiocatalytic System via Cofactor Regeneration for Chiral Aryl Alcohol Synthesis

L-proline-based deep eutectic solvents as green and enantioselective organocatalyst/media for aldol reaction